Code of Federal Regulations: Containing a Codification of Documents of General Applicability and Future Effect as of December 31, 1948, with Ancillaries and IndexDivision of the Federal Register, the National Archives, 1998 Special edition of the Federal Register, containing a codification of documents of general applicability and future effect ... with ancillaries. |
No grāmatas satura
6.10. rezultāts no 100.
508. lappuse
... Identity . Proceed as directed in § 436.211 of this chapter , using a 1 per- cent potassium bromide disc prepared as directed in paragraph ( b ) ( 1 ) of that section . ( 7 ) Crystallinity . Proceed as directed in § 436.203 ( a ) of ...
... Identity . Proceed as directed in § 436.211 of this chapter , using a 1 per- cent potassium bromide disc prepared as directed in paragraph ( b ) ( 1 ) of that section . ( 7 ) Crystallinity . Proceed as directed in § 436.203 ( a ) of ...
514. lappuse
... identity , strength , quality , and purity . Sterile nafcillin sodium monohydrate is the monohydrated so- salt of 6- ( 2 - ethoxy - 1- naphthamido ) penicillanic acid . It is so purified and dried that : dium ( i ) It contains not less ...
... identity , strength , quality , and purity . Sterile nafcillin sodium monohydrate is the monohydrated so- salt of 6- ( 2 - ethoxy - 1- naphthamido ) penicillanic acid . It is so purified and dried that : dium ( i ) It contains not less ...
526. lappuse
... identity , strength , quality , and purity . Amoxicillin trihydrate cap- sules are composed of amoxicillin tri- hydrate with or without one or more suitable and harmless lubricants , diluents , and drying agents , enclosed in a gelatin ...
... identity , strength , quality , and purity . Amoxicillin trihydrate cap- sules are composed of amoxicillin tri- hydrate with or without one or more suitable and harmless lubricants , diluents , and drying agents , enclosed in a gelatin ...
527. lappuse
... identity . ( b ) The batch for potency , moisture , pH , and identity . ( ii ) Samples required : ( a ) The amoxicillin trihydrate used in making the batch : 12 packages , each containing approximately 300 milli- grams . ( b ) The batch ...
... identity . ( b ) The batch for potency , moisture , pH , and identity . ( ii ) Samples required : ( a ) The amoxicillin trihydrate used in making the batch : 12 packages , each containing approximately 300 milli- grams . ( b ) The batch ...
528. lappuse
... identity . ( b ) The batch for potency , moisture , and identity . ( ii ) Samples required : ( a ) The amoxicillin trihydrate used in making the batch : 12 packages , each containing approximately 300 milli- grams . ( b ) The batch : A ...
... identity . ( b ) The batch for potency , moisture , and identity . ( ii ) Samples required : ( a ) The amoxicillin trihydrate used in making the batch : 12 packages , each containing approximately 300 milli- grams . ( b ) The batch : A ...
Saturs
279 | |
285 | |
290 | |
299 | |
310 | |
331 | |
339 | |
340 | |
223 | |
236 | |
238 | |
239 | |
240 | |
256 | |
257 | |
262 | |
263 | |
265 | |
270 | |
275 | |
351 | |
483 | |
588 | |
593 | |
696 | |
699 | |
761 | |
826 | |
865 | |
890 | |
911 | |
949 | |
Citi izdevumi - Skatīt visu
Bieži izmantoti vārdi un frāzes
abbre abbreviated application abbreviated new drug acid active ingredient adverse drug experience agency amended antibiotic application or abbreviated bacitracin bioavailability bioequivalence cation Center for Drug certification chapter clinical hold clinical investigation conducted control number copy Cosmetic Act digoxin dosage form dose Drug Administration drug application Drug Evaluation drug prod drug product Drug products containing drug substance Evaluation and Research Federal Food Food and Drug graph gredients hearing hydrochloride identified information requirements ap insulin intended inves investigational new drug labeling manufacturer marketing meet ment milligrams milliliters misbranded neomycin notice oral dosage orphan drug OTC drug product package paragraph percent person plication polymyxin proposed protocol recognized as safe reference listed drug request safe and effective safety section 502 Sodium sponsor statement submission Subpart sulfate tained tigational tion tive treatment treatment IND vestigational viated warning